UACOOPERA University of AveirouacooperaUACOOPERA University of Aveiro posted this:
Technology Transfer Office at uacoopera
Universidad de Alcalá-OTRIUniversidad de Alcalá-OTRIUniversidad de Alcalá-OTRI posted this:
Emotongue: A software for every customer with a Smartphone (Android) interested in managing their own emotions and for companies interested in their employees’ emotional healthSUMMARY Emotongue is an application for smartphones with the Android System, designed in Spanish and English, so that every customer who speaks one or both of them could easily use it every time and everywhere, having a data connection. Emotongue is not a simple app, it is the app that everybody was looking for! It had been designed for a research project carried out in the Department of Sciences of Education of the University of Alcalá, Spain, but due to its features and the great benefits it has, now it is available for every customer interested in improving his/her resources for managing his/her emotional world. Emotongue has been created for helping people to know their emotions, connect with them and learn how to manage them. The app is a tool easy to use, with a colored and dynamic design. It sends the user 5 notifications per day, and she/he has at his/her disposal 2 hours to answer each notification either by a written message or by an audio. The app is available in every country in which people speak English and/or Spanish. An improved version of the app could send users a feedback about their evolution in their management of their emotions and their use of the app. A part from the app, the authors could offer a service to companies interested in it, by creating courses about emotional management, designed according to the company’s needs, something very difficult to find in the trade market.
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Immunoassay for rapid diagnosis of infectious diseases caused by Pseudomonasaeruginosa CSIC, CIBER-BBN and UAB have developed an immunochemical method for diagnosis of infections produced by Pseudomonas aeruginosa. The immunoassay is fast and efficient, with low LOD and adaptable to point-of care devices.
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Biocatalysts for the food, pharmaceutical and cosmetic industry made from used batteriesThe CSIC has developed a system that use the black mass of the used batteries to synthesize biocatalysts with a great capacity to synthesize products widely used in the food, pharmaceutical and cosmetic industry, such as aromas and flavorings. Companies interested in exploiting the technology under a patent license are sought. An offer for Patent Licensing
Alexander KvashninCenter for Technology Transfer and Commercialization of Novosibirsk State UniversityDirector at Center for Technology Transfer and Commercialization of Novosibirsk State University
View ProfileAlexander Kvashnin posted this:
Director at Center for Technology Transfer and Commercialization of Novosibirsk State University
Unitat de Valorització de la URVFundació URVUnitat de Valorització de la URV posted this:
Licensing Manager at Fundació URV
Unitat de Valorització de la URVFundació URVUnitat de Valorització de la URV posted this:
Licensing Manager at Fundació URV
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
New antioxidant compounds: Polyphenols amide derivativesCSIC has synthetized and studied unknown polyphenolic compounds possessing high antioxidant activity, comparable and in some cases even higher than those of known natural polyphenols, as resveratrol and hydroxytyrosol. We are seeking for Pharmaceutical, Biotechnological, Food or Cosmetics companies interested in developing and marketing these compounds as drugs, cosmetics ingredients or dietary supplements under patent licensing. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Chimeric protein with high antimicrobial activityResearchers from CSIC have developed a chimeric protein (ClyRODI-H5) with an improved lytic activity against Staphylococcus sp. and higher stability than the parental endolysins of the state of the art. Thus, the invention relates to this chimeric protein and its use as an antimicrobial for treating and/or preventing staphylococcal infections without generation of resistant bacteria; for removing and/or preventing staphylococcal biofilms formation on abiotic surfaces, or for removing and/or preventing staphylococcal contamination of foods. Thus, the present invention belongs to the field of the treatment of bacterial contamination and/or infections. Industrial partners or companies from the food or pharmaceutical field are being sought to collaborate through a patent license agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Microorganism and method to produce urolithinsProfessor Francisco Tomas group at CEBAS-CSIC has isolated and characterized the first urolithins- producing microorganism from ellagic acid and ellagitannins present in the diet. A urolithin producing method based on the use of the mentioned microorganism has been developed and both, the microorganism and the method are part of a Spanish priority patent application assigned to CSIC. Biotech companies, functional food or nutraceutical companies are sought for license and/or development agreements. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Obtaining of food-grade natural prebiotic oligosaccharides by enzymatic synthesis from disaccharidesCSIC has developed an enzymatic synthesis procedure of lactosil-fructosilated derivatives obtained from natural disaccharides. Lactosil-fructosilated derivatives are prebiotics potentially usable in healthy food compositions to prevent diseases of the gastrointestinal system. Looking for food or pharmaceutical companies to develop and produce the compound under patent license. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Test for oral tolerance to triglycerides in humansThe Instituto de la Grasa of CSIC and University of Seville have developed a fast and simple procedure to evaluate the tolerance to dietary fats (triglycerides) in humans. A novel emulsified composition, easy to take and digest, is supplied to patients, and then the peak of triglycerides in blood and their clearance are determine in a short period of 4 hours. Companies interested in exploiting this technology under a patent license are sought. An offer for patent licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Myt-healer: a new potent wound healing peptideCSIC and the University Miguel Hernández have developed a minimal peptide core from the M yti lus galloprovidencialis Myticin C peptide with unique in vitro and in vivo wound healing and regenerating activities. Industrial partners from the pharmaceutical and cosmetic industry are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Modulating compounds of KChIP2 and its use for the treatment of cardiovascularppaatthhoollooggiieess CSIC and UAM have developed compounds that positively modulate protein-protein interactions that involve KChIP2 protein. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
OPTOBIOTICS: Novel antibacterial proteins activated by blue lightCSIC has developed a chimeric protein that, when expressed in bacteria, changes its structure upon absorption of blue light, thus generating protein aggregates (amyloids) that inhibit bacterial growth Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement An offer for Patent Licensing
